|Addressing clinical & translational research needs associated with child health.||Child Health|
Harvard Catalyst's Child Health Program ensures that Harvard Catalyst attends to the pediatric population in all aspects of its work. In particular, the program helps to integrate Harvard Catalyst resources into pediatric instructions and programs across the Harvard community, promotes C/T research devoted to child health, and fosters the education and training of junior investigators interested in child health research and the pediatric antecedents of adult disease.
Child Health in Harvard Catalyst includes the large, pediatric-centered efforts at Boston Children's Hospital (BCH) and Massachusetts General Hospital (MGH) for Children, as well as the neonatology programs at Beth Israel Deaconess Medical Center and Brigham and Women's Hospital, pediatric oncology at Dana-Farber Cancer Institute, and many child-health focused initiatives in the community and among the many Harvard Catalyst member institutions. Inpatient clinical research facilities include Harvard Catalyst Clinical Research Center sites at BCH and MGH the Clinical and Translational Research Unit at Children's (part of the Harvard Catalyst Clinical Research Center), and the HCCRC at MGH. Outpatient facilities include HCCRC site at BCH's facility in Waltham.
Representatives of the Child Health Program participate actively on every Harvard Catalyst program committee, including the Pilot Funding review committees. In addition, Harvard Catalyst pediatrics representatives are active in many areas of the national CTSA consortium, including bioinformatics, biomedical ethics, and the Child-Health Oversight Committee.